Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Terry Fry

Concepts (461)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Immunotherapy, Adoptive
39
2025
358
9.290
Why?
T-Lymphocytes
58
2025
1996
6.200
Why?
Antigens, CD19
26
2025
137
4.390
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
13
2023
80
3.850
Why?
Graft vs Host Disease
20
2023
256
3.500
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
2025
288
3.230
Why?
CD8-Positive T-Lymphocytes
19
2025
911
2.960
Why?
Hematopoietic Stem Cell Transplantation
26
2023
670
2.880
Why?
Receptors, Antigen, T-Cell
18
2023
716
2.720
Why?
Sialic Acid Binding Ig-like Lectin 2
10
2025
18
2.650
Why?
Immunotherapy
16
2024
641
2.610
Why?
Interleukin-7
23
2012
62
2.370
Why?
Dendritic Cells
11
2016
487
2.340
Why?
Cancer Vaccines
9
2018
165
1.870
Why?
CD4-Positive T-Lymphocytes
11
2023
1111
1.770
Why?
Hematologic Neoplasms
8
2023
159
1.720
Why?
Leukemia, Myeloid, Acute
6
2025
653
1.700
Why?
Lymphoma, B-Cell
8
2025
131
1.620
Why?
Bone Marrow Transplantation
9
2023
292
1.250
Why?
Lymphocyte Transfusion
4
2017
20
1.210
Why?
Adoptive Transfer
10
2019
219
1.120
Why?
Graft vs Leukemia Effect
4
2017
12
0.980
Why?
Mice
45
2025
17969
0.960
Why?
Cytokines
12
2022
2079
0.920
Why?
Animals
61
2025
37328
0.910
Why?
Dipeptides
3
2014
55
0.900
Why?
H-Y Antigen
5
2013
7
0.880
Why?
Neoplasms
13
2023
2731
0.870
Why?
T-Box Domain Proteins
1
2025
102
0.870
Why?
Antigens, Neoplasm
5
2019
320
0.840
Why?
Cell Line, Tumor
16
2025
3502
0.830
Why?
Graft vs Tumor Effect
3
2021
8
0.800
Why?
Tumor Escape
3
2021
47
0.720
Why?
Humans
111
2025
141284
0.720
Why?
Sialic Acid Binding Ig-like Lectin 3
1
2021
10
0.720
Why?
Cell Adhesion Molecules
1
2022
179
0.690
Why?
Receptors, Cytokine
2
2024
36
0.680
Why?
Immune System
5
2010
183
0.680
Why?
Perforin
1
2020
19
0.670
Why?
Precursor Cells, B-Lymphoid
2
2018
41
0.670
Why?
Thymus Gland
6
2004
316
0.660
Why?
Leukemia
5
2025
243
0.660
Why?
Retinal Neoplasms
1
2020
36
0.650
Why?
Retinoblastoma
1
2020
40
0.650
Why?
WT1 Proteins
2
2018
13
0.650
Why?
Xenograft Model Antitumor Assays
8
2025
917
0.630
Why?
Myelodysplastic Syndromes
5
2023
143
0.620
Why?
Recurrence
13
2025
1108
0.620
Why?
Lymphoma
2
2019
228
0.620
Why?
Transplantation, Homologous
9
2018
411
0.610
Why?
T-Lymphocyte Subsets
6
2023
413
0.600
Why?
Adjuvants, Immunologic
4
2014
238
0.600
Why?
Erythropoietin
1
2020
98
0.590
Why?
Allergy and Immunology
1
2019
41
0.590
Why?
Neoplasms, Experimental
2
2019
174
0.590
Why?
Mice, Inbred C57BL
17
2021
5866
0.540
Why?
Genetic Engineering
2
2019
92
0.510
Why?
Boron Compounds
2
2014
30
0.510
Why?
Calcitonin
1
2016
29
0.510
Why?
Hematopoietic Stem Cells
4
2016
408
0.500
Why?
Immunologic Memory
8
2025
358
0.500
Why?
Cell Lineage
2
2016
352
0.500
Why?
Child
34
2023
22390
0.480
Why?
Cell Plasticity
1
2016
37
0.480
Why?
Leukapheresis
2
2017
26
0.470
Why?
Lymphocyte Activation
11
2021
1136
0.470
Why?
Antigens, CD
2
2017
537
0.460
Why?
Disease Models, Animal
7
2020
4414
0.450
Why?
Donor Selection
1
2015
77
0.450
Why?
Apoptosis
8
2019
2487
0.440
Why?
Homeostasis
6
2006
632
0.430
Why?
STAT1 Transcription Factor
1
2014
71
0.430
Why?
Mice, Knockout
7
2020
3042
0.420
Why?
Photopheresis
2
2011
9
0.420
Why?
Dipeptidyl-Peptidase IV Inhibitors
2
2014
48
0.420
Why?
Rhabdomyosarcoma
2
2014
62
0.410
Why?
Signal Transduction
8
2025
5116
0.410
Why?
Receptors, G-Protein-Coupled
1
2015
216
0.410
Why?
Drug Resistance, Neoplasm
5
2024
840
0.400
Why?
Recombinant Fusion Proteins
4
2017
672
0.400
Why?
Boronic Acids
1
2013
34
0.390
Why?
Pore Forming Cytotoxic Proteins
1
2012
15
0.390
Why?
Lymphocyte Depletion
8
2014
136
0.380
Why?
Vaccination
2
2012
1468
0.380
Why?
STAT3 Transcription Factor
1
2014
211
0.380
Why?
Neoplasm Proteins
1
2015
435
0.370
Why?
Female
49
2025
75814
0.360
Why?
Flow Cytometry
6
2020
1182
0.360
Why?
Siblings
4
2014
216
0.360
Why?
Antigens, CD34
2
2011
88
0.360
Why?
Mice, Inbred C3H
4
2014
255
0.350
Why?
Neurotoxicity Syndromes
2
2024
39
0.350
Why?
Living Donors
3
2014
269
0.340
Why?
Lymphohistiocytosis, Hemophagocytic
2
2021
29
0.340
Why?
Protein Domains
2
2025
305
0.340
Why?
Neoplasm, Residual
3
2020
130
0.340
Why?
Young Adult
18
2025
13727
0.340
Why?
Adult
30
2025
39319
0.340
Why?
Antigen Presentation
2
2009
213
0.340
Why?
Neoplasm Metastasis
3
2016
674
0.330
Why?
Receptors, Interleukin-7
5
2011
27
0.320
Why?
Adolescent
23
2025
22116
0.320
Why?
Transplantation Conditioning
4
2018
184
0.310
Why?
Lymphocyte Count
4
2017
167
0.310
Why?
Gene Expression
5
2020
1490
0.300
Why?
Male
40
2025
70140
0.300
Why?
Urinary Bladder Neoplasms
2
2009
255
0.300
Why?
Receptors, Interferon
1
2009
52
0.290
Why?
Interleukin-10
1
2011
305
0.290
Why?
Sarcoma, Ewing
2
2012
100
0.290
Why?
Models, Immunological
4
2020
101
0.280
Why?
Clinical Trials as Topic
4
2019
1035
0.270
Why?
Monocytes
1
2011
544
0.270
Why?
Remission Induction
4
2017
306
0.270
Why?
Social Adjustment
1
2008
64
0.270
Why?
Child, Preschool
15
2023
11511
0.270
Why?
Mutation
2
2015
4006
0.270
Why?
Drug-Related Side Effects and Adverse Reactions
2
2020
254
0.260
Why?
Killer Cells, Natural
3
2021
467
0.260
Why?
Carcinoma
1
2009
230
0.260
Why?
Receptors, Antigen
2
2017
17
0.250
Why?
Gene Rearrangement
2
2024
148
0.250
Why?
Allografts
3
2018
148
0.250
Why?
Lymphopoiesis
2
2006
26
0.250
Why?
Neuroblastoma
2
2021
162
0.240
Why?
Mice, Transgenic
7
2021
2165
0.230
Why?
Prognosis
7
2020
4080
0.230
Why?
Interferon-gamma
1
2009
784
0.230
Why?
Unsupervised Machine Learning
1
2025
23
0.230
Why?
Immunocompromised Host
2
2010
201
0.230
Why?
Stem Cell Transplantation
1
2006
186
0.220
Why?
Philadelphia Chromosome
1
2024
19
0.220
Why?
Core Binding Factor Alpha 1 Subunit
1
2025
44
0.220
Why?
Neoplasm Recurrence, Local
3
2023
1075
0.220
Why?
Disease Progression
5
2021
2808
0.220
Why?
Unrelated Donors
3
2023
38
0.220
Why?
Tissue Donors
4
2018
406
0.220
Why?
HIV Infections
5
2008
2981
0.220
Why?
Cytotoxicity, Immunologic
1
2025
221
0.210
Why?
Transplantation, Autologous
5
2018
282
0.210
Why?
Treatment Outcome
12
2025
11216
0.210
Why?
MAP Kinase Kinase Kinases
1
2024
71
0.210
Why?
Lentivirus
3
2019
59
0.210
Why?
T-Lymphocytes, Regulatory
4
2017
393
0.200
Why?
Peripheral Blood Stem Cell Transplantation
2
2014
33
0.200
Why?
Combined Modality Therapy
4
2021
1243
0.200
Why?
Interleukin-15
4
2014
99
0.200
Why?
Regeneration
2
2004
196
0.200
Why?
Protein Binding
3
2025
2233
0.200
Why?
Macrophages
1
2011
1478
0.200
Why?
fms-Like Tyrosine Kinase 3
1
2023
47
0.190
Why?
Genetic Vectors
3
2019
336
0.180
Why?
Mice, SCID
4
2019
367
0.180
Why?
Antineoplastic Agents, Immunological
2
2021
191
0.180
Why?
Burkitt Lymphoma
1
2022
63
0.180
Why?
Simian Acquired Immunodeficiency Syndrome
1
2002
92
0.180
Why?
Microglia
1
2024
254
0.180
Why?
Gangliosides
1
2021
22
0.180
Why?
Lymphopenia
4
2011
67
0.170
Why?
Thrombocytopenia
1
2023
206
0.170
Why?
Coculture Techniques
2
2012
244
0.170
Why?
Bone Marrow
3
2020
298
0.170
Why?
Capillary Leak Syndrome
1
2020
12
0.170
Why?
Exotoxins
1
2020
16
0.170
Why?
Recovery of Function
1
2005
684
0.170
Why?
Macrophage Activation Syndrome
1
2020
22
0.170
Why?
Myeloid-Lymphoid Leukemia Protein
1
2021
69
0.170
Why?
Image Processing, Computer-Assisted
1
2025
768
0.170
Why?
Anxiety
1
2008
1078
0.160
Why?
Immunotoxins
1
2020
55
0.160
Why?
Cyclophosphamide
4
2023
257
0.160
Why?
Leukemia, B-Cell
1
2020
13
0.160
Why?
Mice, Inbred NOD
3
2019
599
0.160
Why?
Bacterial Toxins
1
2020
104
0.160
Why?
B-Lymphocytes
4
2018
857
0.160
Why?
Immunodominant Epitopes
2
2012
27
0.160
Why?
Clinical Studies as Topic
1
2019
12
0.150
Why?
Pediatrics
1
2008
1102
0.150
Why?
Proto-Oncogene Proteins c-cbl
1
2019
12
0.150
Why?
Histone-Lysine N-Methyltransferase
1
2021
134
0.150
Why?
Cell Proliferation
6
2024
2502
0.150
Why?
Interleukin-3 Receptor alpha Subunit
1
2019
17
0.150
Why?
Epitopes
2
2018
476
0.150
Why?
In Vitro Techniques
1
2020
1059
0.150
Why?
Immunomodulation
1
2019
100
0.150
Why?
Cell Membrane
2
2020
704
0.140
Why?
Multiple Myeloma
1
2021
280
0.140
Why?
Immunologic Factors
1
2020
249
0.140
Why?
History, 21st Century
1
2019
218
0.140
Why?
Cryopreservation
1
2019
105
0.140
Why?
Cell- and Tissue-Based Therapy
2
2018
82
0.140
Why?
Autoantigens
2
2019
424
0.140
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2012
1791
0.140
Why?
History, 20th Century
1
2019
324
0.140
Why?
Down Syndrome
1
2024
504
0.140
Why?
Membrane Proteins
1
2004
1144
0.140
Why?
Follow-Up Studies
5
2021
5222
0.140
Why?
Secondary Prevention
1
2019
241
0.140
Why?
Graft Survival
3
2011
502
0.140
Why?
Fas Ligand Protein
2
2019
58
0.130
Why?
Cell Division
3
2012
792
0.130
Why?
Inflammation Mediators
1
2020
507
0.130
Why?
Chromatin
2
2023
536
0.130
Why?
Salvage Therapy
2
2023
154
0.130
Why?
Tumor Microenvironment
2
2019
711
0.130
Why?
Cell Engineering
1
2017
14
0.130
Why?
Immunophenotyping
2
2020
325
0.130
Why?
Cell Culture Techniques
1
2019
368
0.130
Why?
Cytomegalovirus Infections
1
2018
197
0.130
Why?
Spine
1
2018
179
0.130
Why?
Lymph Nodes
3
2013
494
0.130
Why?
Stem Cell Research
1
2016
1
0.120
Why?
CD4 Lymphocyte Count
4
2008
273
0.120
Why?
Receptors, Calcium-Sensing
1
2015
6
0.120
Why?
Retrospective Studies
9
2023
16447
0.120
Why?
Stem Cell Niche
1
2016
58
0.120
Why?
Clone Cells
1
2016
267
0.120
Why?
Infant
8
2018
9820
0.120
Why?
PAX5 Transcription Factor
1
2015
14
0.120
Why?
Antineoplastic Agents
3
2019
2162
0.120
Why?
STAT Transcription Factors
1
2015
16
0.120
Why?
Janus Kinases
1
2015
15
0.120
Why?
Transcription Factors
1
2023
1706
0.120
Why?
Gene Editing
1
2016
87
0.120
Why?
Lymphoma, Large B-Cell, Diffuse
1
2018
190
0.120
Why?
Receptor Protein-Tyrosine Kinases
1
2017
226
0.110
Why?
Tumor Necrosis Factor Receptor Superfamily, Member 9
1
2015
27
0.110
Why?
Myeloid Cells
1
2016
147
0.110
Why?
Cell Line
2
2017
2863
0.110
Why?
Receptors, Cell Surface
1
2017
375
0.110
Why?
4-1BB Ligand
1
2014
7
0.110
Why?
Aging
3
2002
1919
0.110
Why?
Prospective Studies
5
2023
7805
0.110
Why?
Calgranulin B
1
2014
10
0.110
Why?
Growth
1
1994
52
0.110
Why?
Calgranulin A
1
2014
11
0.110
Why?
Models, Biological
3
2009
1810
0.110
Why?
Mice, 129 Strain
1
2014
86
0.110
Why?
Survival Analysis
2
2017
1322
0.110
Why?
Erythrocytes
1
2020
698
0.110
Why?
Virus Replication
1
2017
533
0.110
Why?
Growth Disorders
1
1994
87
0.110
Why?
Mice, Inbred BALB C
2
2021
1261
0.100
Why?
Genome
1
2016
303
0.100
Why?
Phenotype
4
2019
3172
0.100
Why?
Gastrointestinal Neoplasms
1
2014
75
0.100
Why?
Attitude to Health
2
2008
451
0.100
Why?
Body Height
1
1994
200
0.100
Why?
Alternative Splicing
1
2015
232
0.100
Why?
T-Lymphocytes, Cytotoxic
1
2014
173
0.100
Why?
Recombinant Proteins
6
2011
1362
0.100
Why?
Transduction, Genetic
3
2019
135
0.100
Why?
fas Receptor
2
2019
93
0.100
Why?
Lymphoma, Non-Hodgkin
1
2014
123
0.100
Why?
Incidence
2
2018
2809
0.100
Why?
Animals, Congenic
1
2012
9
0.100
Why?
Radiation Chimera
1
2012
27
0.100
Why?
Specific Pathogen-Free Organisms
1
2012
59
0.100
Why?
Proteins
1
2019
1007
0.100
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2012
51
0.100
Why?
CD3 Complex
3
2017
106
0.100
Why?
Minor Histocompatibility Antigens
1
2012
46
0.100
Why?
Treatment Failure
2
2014
355
0.090
Why?
Carcinoma, Transitional Cell
1
2012
70
0.090
Why?
Tumor Burden
1
2013
314
0.090
Why?
Antigen-Presenting Cells
2
2010
158
0.090
Why?
Chemokines
1
2013
223
0.090
Why?
Tissue and Organ Procurement
1
2016
319
0.090
Why?
Body Weight
2
2002
992
0.090
Why?
Blood Component Removal
1
2011
28
0.090
Why?
CD28 Antigens
2
2025
57
0.090
Why?
Interleukin-6
1
2015
775
0.090
Why?
Epigenesis, Genetic
1
2016
661
0.090
Why?
CD4-CD8 Ratio
2
2019
24
0.090
Why?
Methoxsalen
1
2011
4
0.090
Why?
Spleen
2
2011
512
0.090
Why?
Adenovirus Infections, Human
1
2010
15
0.080
Why?
Brain Neoplasms
2
2011
1282
0.080
Why?
Cytosine
1
2010
48
0.080
Why?
Blood
1
2011
110
0.080
Why?
Alleles
1
2013
878
0.080
Why?
Antiretroviral Therapy, Highly Active
2
2002
278
0.080
Why?
Organophosphonates
1
2010
96
0.080
Why?
Hematopoiesis
3
2016
193
0.080
Why?
Antiviral Agents
2
2018
748
0.080
Why?
Acute Disease
3
2023
1005
0.080
Why?
Transplantation Immunology
1
2009
31
0.080
Why?
Ophthalmoplegia
1
1989
13
0.080
Why?
Paranasal Sinus Neoplasms
1
1989
29
0.080
Why?
Laryngeal Neoplasms
1
1989
34
0.080
Why?
Sarcoma
1
2011
193
0.070
Why?
Intestinal Neoplasms
1
2009
31
0.070
Why?
Hematopoietic System
1
2008
8
0.070
Why?
Virus Diseases
1
2011
218
0.070
Why?
Interleukin-12
1
2009
122
0.070
Why?
Cell Differentiation
4
2023
1983
0.070
Why?
Sibling Relations
1
2008
11
0.070
Why?
Substrate Specificity
1
2009
380
0.070
Why?
National Cancer Institute (U.S.)
1
2008
48
0.070
Why?
Lymphocyte Subsets
2
2014
87
0.070
Why?
Ultraviolet Rays
1
2011
399
0.070
Why?
Psychology
1
2008
89
0.070
Why?
Lipopolysaccharides
1
2011
854
0.070
Why?
Skin Neoplasms
1
2014
851
0.070
Why?
Cells, Cultured
2
2014
4149
0.070
Why?
Biomarkers
2
2016
4180
0.070
Why?
Tumor Cells, Cultured
1
2009
959
0.060
Why?
Macaca fascicularis
2
2007
69
0.060
Why?
Immune Tolerance
2
2010
373
0.060
Why?
Brain
1
2018
2857
0.060
Why?
Ki-67 Antigen
2
2004
111
0.060
Why?
Proto-Oncogene Proteins c-bcl-2
2
2008
243
0.060
Why?
Polymerase Chain Reaction
2
2022
1050
0.050
Why?
Immunologic Surveillance
1
2004
26
0.050
Why?
Middle Aged
8
2025
34658
0.050
Why?
Carcinoma, Squamous Cell
1
1989
641
0.050
Why?
Nitriles
1
2024
189
0.050
Why?
Hemostasis
1
2004
100
0.050
Why?
United States
4
2018
15298
0.050
Why?
Obesity
2
2022
3007
0.050
Why?
p38 Mitogen-Activated Protein Kinases
1
2024
272
0.050
Why?
CD47 Antigen
1
2023
43
0.050
Why?
Aged
6
2025
24836
0.050
Why?
Autoimmune Diseases
1
2006
463
0.050
Why?
Gene Rearrangement, T-Lymphocyte
1
2002
16
0.050
Why?
Histocompatibility Testing
2
2014
121
0.050
Why?
DNA Copy Number Variations
1
2022
178
0.040
Why?
Real-Time Polymerase Chain Reaction
1
2022
343
0.040
Why?
Cohort Studies
3
2014
5809
0.040
Why?
United Kingdom
2
2009
321
0.040
Why?
Thymectomy
1
2001
15
0.040
Why?
Body Mass Index
1
2009
2390
0.040
Why?
Pyrimidines
1
2024
510
0.040
Why?
Pyrazoles
1
2024
482
0.040
Why?
HIV Protease Inhibitors
1
2001
67
0.040
Why?
Ritonavir
1
2001
72
0.040
Why?
Skin Transplantation
1
2001
84
0.040
Why?
Cell Survival
2
2019
1123
0.040
Why?
NF-kappa B
1
2024
684
0.040
Why?
Lymphocytes
1
2002
390
0.040
Why?
Fatal Outcome
1
2020
309
0.040
Why?
Subcutaneous Emphysema
1
1999
1
0.040
Why?
Fas-Associated Death Domain Protein
1
2019
9
0.040
Why?
Single-Chain Antibodies
1
2019
17
0.040
Why?
Postoperative Complications
1
2011
2831
0.040
Why?
Vulva
1
1999
24
0.040
Why?
Mice, Nude
1
2001
700
0.040
Why?
Proto-Oncogene Proteins
1
2002
621
0.040
Why?
K562 Cells
1
2019
95
0.040
Why?
Up-Regulation
3
2008
851
0.040
Why?
Pneumatosis Cystoides Intestinalis
1
1999
21
0.040
Why?
Age Factors
3
2011
3295
0.040
Why?
Guidelines as Topic
1
2020
269
0.040
Why?
Transgenes
1
2019
185
0.040
Why?
Immunization
1
2001
402
0.040
Why?
Mental Status and Dementia Tests
1
2018
26
0.040
Why?
Hallucinations
1
2018
31
0.040
Why?
Confusion
1
2018
31
0.040
Why?
Cancer Care Facilities
1
2018
43
0.030
Why?
National Institutes of Health (U.S.)
1
2018
132
0.030
Why?
Epitopes, T-Lymphocyte
1
2019
181
0.030
Why?
Risk Factors
4
2018
10490
0.030
Why?
Positron-Emission Tomography
1
2019
309
0.030
Why?
Steroids
1
2018
163
0.030
Why?
Gene Order
1
2017
27
0.030
Why?
Graft Rejection
1
2001
545
0.030
Why?
Interdisciplinary Communication
1
2018
190
0.030
Why?
Weight Loss
1
2002
794
0.030
Why?
Advisory Committees
1
2018
214
0.030
Why?
Molecular Targeted Therapy
1
2020
420
0.030
Why?
Transfection
1
2019
932
0.030
Why?
Disease-Free Survival
1
2018
713
0.030
Why?
HEK293 Cells
1
2019
738
0.030
Why?
Cell Cycle
1
2019
601
0.030
Why?
Protein Engineering
1
2017
109
0.030
Why?
Research Subjects
1
2016
43
0.030
Why?
Ethics Committees, Research
1
2016
42
0.030
Why?
Time Factors
4
2008
6951
0.030
Why?
Medical Oncology
1
2018
316
0.030
Why?
Serine-Arginine Splicing Factors
1
2015
23
0.030
Why?
Cell Adhesion
1
2017
448
0.030
Why?
Genetic Therapy
1
2017
315
0.030
Why?
Anti-HIV Agents
1
2002
853
0.030
Why?
Health Policy
1
2018
385
0.030
Why?
Surveys and Questionnaires
1
2008
5948
0.030
Why?
Infant, Newborn
2
2018
6270
0.030
Why?
Chimera
1
2014
60
0.030
Why?
Transplantation Chimera
1
2014
57
0.030
Why?
Reproducibility of Results
1
2022
3345
0.030
Why?
Exons
1
2015
352
0.030
Why?
Societies, Medical
1
2018
859
0.030
Why?
Interleukin-2
1
2015
448
0.030
Why?
Neoplasm Transplantation
1
2014
251
0.030
Why?
Longitudinal Studies
1
2001
2929
0.030
Why?
Reference Values
1
1994
803
0.020
Why?
Transcriptome
1
2019
1007
0.020
Why?
Sequence Analysis, DNA
1
2015
815
0.020
Why?
Neoplastic Stem Cells
1
2016
411
0.020
Why?
Vidarabine
1
2012
35
0.020
Why?
Colonic Neoplasms
1
2014
244
0.020
Why?
Antibodies, Monoclonal, Murine-Derived
1
2012
95
0.020
Why?
Etoposide
1
2012
163
0.020
Why?
RNA-Binding Proteins
1
2015
448
0.020
Why?
Administration, Oral
1
2014
825
0.020
Why?
Vincristine
1
2012
130
0.020
Why?
Prednisone
1
2012
228
0.020
Why?
Rituximab
1
2012
204
0.020
Why?
Feasibility Studies
1
2014
1037
0.020
Why?
Body Fat Distribution
1
2009
47
0.020
Why?
Doxorubicin
1
2012
369
0.020
Why?
Bone Neoplasms
1
2012
249
0.020
Why?
Biomedical Research
1
2016
684
0.020
Why?
Opportunistic Infections
1
2009
46
0.020
Why?
Bacteremia
1
2011
218
0.020
Why?
Kaplan-Meier Estimate
1
2011
910
0.020
Why?
Transcription, Genetic
1
2015
1486
0.020
Why?
Risk
1
2011
903
0.020
Why?
CD8 Antigens
1
2008
75
0.020
Why?
Leukocytes
1
2010
293
0.020
Why?
Lymphatic Metastasis
1
1989
327
0.020
Why?
RNA, Messenger
1
2015
2815
0.020
Why?
Cell Separation
1
2008
309
0.020
Why?
HLA Antigens
1
2008
232
0.020
Why?
HIV
1
2008
248
0.020
Why?
Cell Polarity
1
2007
139
0.020
Why?
Mass Screening
1
1994
1309
0.020
Why?
Magnetic Resonance Imaging
1
2018
3734
0.020
Why?
Body Composition
1
2009
704
0.010
Why?
Forkhead Transcription Factors
1
2006
200
0.010
Why?
Catheter Ablation
1
2009
336
0.010
Why?
Adiposity
1
2009
520
0.010
Why?
Bone Marrow Cells
1
2006
316
0.010
Why?
Annexin A5
1
2004
25
0.010
Why?
Interleukins
1
2006
250
0.010
Why?
Tomography, X-Ray Computed
2
1999
2765
0.010
Why?
Coloring Agents
1
2004
96
0.010
Why?
Stromal Cells
1
2004
117
0.010
Why?
Macaca mulatta
1
2004
189
0.010
Why?
Tissue Distribution
1
2004
325
0.010
Why?
Sensitivity and Specificity
1
2008
1973
0.010
Why?
Immunosuppressive Agents
1
2008
855
0.010
Why?
Predictive Value of Tests
1
2008
2069
0.010
Why?
bcl-2-Associated X Protein
1
2002
53
0.010
Why?
Immunity, Innate
1
2009
847
0.010
Why?
Models, Genetic
1
2004
587
0.010
Why?
Transplantation, Isogeneic
1
2001
16
0.010
Why?
Temperature
1
2004
668
0.010
Why?
Leukocyte Common Antigens
1
2001
88
0.010
Why?
Kinetics
1
2004
1620
0.010
Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2002
334
0.010
Why?
Colon
1
2002
295
0.010
Why?
Tumor Necrosis Factor-alpha
1
2004
1220
0.010
Why?
Pubic Bone
1
1999
6
0.010
Why?
Genotype
1
2004
1854
0.010
Why?
Hyperbaric Oxygenation
1
1999
40
0.010
Why?
Risk Assessment
1
2008
3522
0.010
Why?
Radiography, Abdominal
1
1999
44
0.010
Why?
Cardiovascular Diseases
1
2009
2091
0.010
Why?
Antibodies, Monoclonal
1
2004
1456
0.010
Why?
Cross-Sectional Studies
1
2007
5653
0.010
Why?
Liver
1
2002
1821
0.010
Why?
Fry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)